Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Real Time Genomics Appoints Steve Lombardi as CEO

Published: Thursday, April 26, 2012
Last Updated: Thursday, April 26, 2012
Bookmark and Share
Genomics industry veteran will drive commercialization of the company’s highly scalable core technology for next generation genomic analysis.

Real Time Genomics, Inc. announced the appointment of genomics industry veteran Steve Lombardi as the company’s President and Chief Executive Officer. Lombardi will lead the company as it commercializes its highly scalable, patented, core technology for use in next generation genomic analysis.

“We are pleased to have someone of Steve’s caliber join RTG as CEO,” stated Mark Silverman, Partner at Catamount Ventures, the private company’s lead venture investor. “His knowledge of the genomics marketplace and extensive industry relationships make him a perfect fit for the company. With Steve on board, we see RTG making a substantial impact in accelerating customers’ ability to utilize genomic content in research and in the clinic.”

Lombardi has 30+ years of commercial biotechnology experience. He has led the commercialization of key technologies that have defined modern molecular biology, and has been responsible for the largest and fastest growing product lines in the life science tools industry. From 2006 to 2010, Lombardi was President and then CEO of Helicos BioSciences. From 2002 to 2006, he was a senior executive at Affymetrix running corporate development and business management. From 1986 to 2002, Lombardi held increasingly responsible positions at Applied Biosystems in product, sales and business management, including general management of their DNA sequencing business, during which time annual revenues in his division grew from $10M to ~$800M.

“Bioinformatics and computational biology are the next big frontier in genomics,” said Steve Lombardi. “Advances in tools and applications that allow scientists to interpret and extract value from NGS data have driven a renaissance in sequence-based genetic analysis. My goal is to build RTG into the market leader of next generation genomic analysis based on the company’s unique technology. I am excited about working with a great team to make RTG a valuable contributor to the advancement of genomic science and a leading company in the genomics industry.”

The Real Time Genomics mission is to further enable the genomics revolution by providing the best genomics analysis software in the industry. The first step in fulfilling that mission is to apply its patented core technology to solve the bottleneck that currently limits large scale genomic analysis. Today, RTG software addresses some of the most demanding applications of high-throughput sequence data, like providing comprehensive variant detection and metagenomic analysis pipelines. As an example, a complete RTG solution for high-throughput metagenomics was developed in collaboration with The Genome Institute at Washington University in St. Louis for use in the Human Microbiome Project.

“The appointment of Steve Lombardi as CEO is a significant enhancement for Real Time Genomics,” said George Weinstock, Associate Director, The Genome Institute and Professor of Genetics at Washington University in St. Louis. “His industry experience and relationships are invaluable to an emerging company like RTG that has developed a great base of technology. Steve’s industry intuition complements the company’s existing technical know-how and provides an important new ingredient for maturing their technology into world class genomics products.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

RTG and JCVI Embark on Strategic Research Initiative
Long-term collaboration to understand de novo mutations for stem cell progression study and deliver validated, gold-standard datasets.
Friday, May 03, 2013
Scientific News
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
GMO Food Animals Should be Judged by Product, Not Process
In a world with a burgeoning demand for meat, milk and eggs, regulatory policies around the use of biotechnologies in agriculture need to be based on the safety and attributes of those foods rather than on the methods used to produce them, says a UC Davis animal scientist.
Enzyme Critical to Maintaining Telomere Length Discovered
New method expected to speed understanding of short telomere diseases and cancer.
Gene Drive Reversibility Introduces New Layer of Biosafety
Ability to introduce or reverse the spread of genetic traits through populations could one day improve pest management and disease control.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos